Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASA
The Swiss drugmaker will pay $1.1 billion upfront and up to $400 million in milestones to gain a novel antibody-drug conjugate payload platform
Please enable cookies.
Sorry, you have been blocked You are unable to access qz.com
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.
You can email the site owner to let them know you were blocked. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page.
Cloudflare Ray ID: a172d622296208d5 • Your IP: 45.147.101.248 • Performance & security by Cloudflare
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Tempus Is Buying Cancer-Testing Partner Personalis for $1.5 Billion | 0 | 7.88 | 14-08-2026 |
| 2 | Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment | 0 | 7.09 | 26-03-2026 |
| 3 | Sobi strengthens cancer portfolio with $580m deal | 0 | 10 | 12-08-2026 |
| 4 | Novartis rileva Myricx Bio in un’operazione fino a 1,5 miliardi di dollari | 0 | 18.34 | 06-07-2026 |
| 5 | GSK completes acquisition of Nuvalent, Inc. | 0 | 11.9 | 15-07-2026 |
| 6 | GSK announces commencement of tender offer to acquire Nuvalent, Inc. | 0 | 5.74 | 24-06-2026 |
| 7 | AstraZeneca tratta con Bristol Myers Squibb, allo studio una fusione da quasi 400 miliardi di dollari | 0 | 8.38 | 03-08-2026 |
| 8 | 2 Firms Lead Merck's $11.3B Bio-Techne Life Sciences Deal | 0 | 7 | 25-06-2026 |
| 9 | AstraZeneca scraps late‑stage study – and reports dual successes in lung cancer | 0 | 10 | 17-08-2026 |
| 10 | Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug | 5 | 7 | 07-04-2026 |